Benitec Biopharma annual net debt
2020
2021
2022
2023
2024
2025
Benitec Biopharma Net Debt Growth & History (BNTC)
Benitec Biopharma's net debt was −$96.9M for fiscal 2025.
View full Benitec Biopharma company overviewBenitec Biopharma annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-06-30 | −$96.9M | −$46.3M | — |
| 2024 | 2024-06-30 | −$50.6M | −$48.7M | — |
| 2023 | 2023-06-30 | −$1.9M | $1.3M | — |
| 2022 | 2022-06-30 | −$3.3M | $16.3M | — |
| 2021 | 2021-06-30 | −$19.6M | −$10.2M | — |
| 2020 | 2020-06-30 | −$9.4M | — | — |
Benitec Biopharma quarterly net debt
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q3.26
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q3 2026 | 2026-03-31 | −$183.9M | −$81.3M | — |
| Q2 2026 | 2025-12-31 | −$187.8M | −$109.7M | — |
| Q1 2026 | 2025-09-30 | −$93.7M | −$26.0M | — |
| Q4 2025 | 2025-06-30 | −$96.9M | −$46.3M | — |
| Q3 2025 | 2025-03-31 | −$102.6M | −$88.9M | — |
| Q2 2025 | 2024-12-31 | −$78.1M | −$58.2M | — |
| Q1 2025 | 2024-09-30 | −$67.6M | −$42.3M | — |
| Q4 2024 | 2024-06-30 | −$50.6M | −$48.7M | — |
| Q3 2024 | 2024-03-31 | −$13.7M | −$7.8M | — |
| Q2 2024 | 2023-12-31 | −$20.0M | −$10.1M | — |
| Q1 2024 | 2023-09-30 | −$25.4M | −$9.6M | — |
| Q4 2023 | 2023-06-30 | −$1.9M | $1.3M | — |
| Q3 2023 | 2023-03-31 | −$5.9M | $1.8M | — |
| Q2 2023 | 2022-12-31 | −$9.9M | $1.6M | — |
| Q1 2023 | 2022-09-30 | −$15.8M | −$1.0M | — |
| Q4 2022 | 2022-06-30 | −$3.3M | $16.3M | — |
| Q3 2022 | 2022-03-31 | −$7.8M | $4.0M | — |
| Q2 2022 | 2021-12-31 | −$11.4M | $2.3M | — |
| Q1 2022 | 2021-09-30 | −$14.8M | −$7.7M | — |
| Q4 2021 | 2021-06-30 | −$19.6M | −$10.2M | — |
| Q3 2021 | 2021-03-31 | −$11.7M | — | — |
| Q2 2021 | 2020-12-31 | −$13.7M | — | — |
| Q1 2021 | 2020-09-30 | −$7.1M | — | — |
| Q4 2020 | 2020-06-30 | −$9.4M | — | — |
Benitec Biopharma net debt trends
Over the last five fiscal years, Benitec Biopharma's net debt decreased from −$9.4M to −$96.9M, a change of −$87.5M. The latest reported quarter, Q3 2026, shows −$183.9M.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Benitec Biopharma source filings ↗